tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

QNCX Stock Latest News

Quince Therapeutics Reports 2024 Financial Results and Trial Progress
Company AnnouncementsQuince Therapeutics Reports 2024 Financial Results and Trial Progress
19d ago
QNCX
Quince Therapeutics price target lowered to $4 from $12 at D. Boral Capital
PremiumThe Fly
Quince Therapeutics price target lowered to $4 from $12 at D. Boral Capital
20d ago
QNCX
Quince Therapeutics reports FY24 EPS ($1.31), one estimate ($1.17)
PremiumThe Fly
Quince Therapeutics reports FY24 EPS ($1.31), one estimate ($1.17)
20d ago
QNCX
Quince Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
Quince Therapeutics initiated with an Outperform at Oppenheimer
21d ago
QNCX
QNCX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
QNCX Earnings this Week: How Will it Perform?
1M ago
QNCX
Quince Therapeutics gets USPTO notice of allowance in Ataxia-Telangiectasia
PremiumThe FlyQuince Therapeutics gets USPTO notice of allowance in Ataxia-Telangiectasia
2M ago
QNCX
Quince Therapeutics files $200M mixed securities shelf
Premium
The Fly
Quince Therapeutics files $200M mixed securities shelf
4M ago
QNCX
Quince Therapeutics initiated with a Buy at Brookline
Premium
The Fly
Quince Therapeutics initiated with a Buy at Brookline
4M ago
QNCX
Quince Therapeutics management to meet with Maxim Group
PremiumThe Fly
Quince Therapeutics management to meet with Maxim Group
4M ago
QNCX
Quince Therapeutics presents data from prior Phase 3 ATTeST clinical trial
PremiumThe Fly
Quince Therapeutics presents data from prior Phase 3 ATTeST clinical trial
5M ago
QNCX
Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
PremiumThe Fly
Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
5M ago
QNCX
Quince Therapeutics initiated with a Buy at Maxim
PremiumThe Fly
Quince Therapeutics initiated with a Buy at Maxim
5M ago
QNCX
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyQuince Therapeutics initiated with a Buy at Rodman & Renshaw
6M ago
QNCX
Quince Therapeutics initiated with a Buy at EF Hutton
Premium
The Fly
Quince Therapeutics initiated with a Buy at EF Hutton
6M ago
QNCX
Quince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet
Premium
The Fly
Quince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet
8M ago
QNCX
Quince Therapeutics announces first patient dosed in Phase 3 trial of EryDex
PremiumThe Fly
Quince Therapeutics announces first patient dosed in Phase 3 trial of EryDex
10M ago
QNCX
Quince Therapeutics announces fast track designation for EryDex System
PremiumThe Fly
Quince Therapeutics announces fast track designation for EryDex System
11M ago
QNCX
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
PremiumCompany Announcements
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
1y ago
8K
QNCX
Quince Therapeutics Executive Compensation and Stock Option Update
PremiumCompany Announcements
Quince Therapeutics Executive Compensation and Stock Option Update
1y ago
8K
QNCX
Quince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
PremiumThe FlyQuince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
2y ago
QNCX
Quince to acquire EryDel in up-front stock deal + potential milestone
Premium
The Fly
Quince to acquire EryDel in up-front stock deal + potential milestone
2y ago
QNCX
Quince to acquire EryDel and Ataxia-Telangiectasia
Premium
The Fly
Quince to acquire EryDel and Ataxia-Telangiectasia
2y ago
QNCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >